Gainers & Losers
Tue Mar 10 2026 09:55:56- Tata Motors Passenger Vehi...
- ₹345.404.05%
- Mahindra & Mahindra Ltd share price
- ₹3,305.603.71%
- ICICI Bank share price
- ₹1,314.702.92%
- Asian Paints share price
- ₹2,284.402.87%
- Maruti Suzuki India share price
- ₹13,890.002.85%
Active Stocks
Tue Mar 10 2026 10:29:02- Eternal share price
- ₹226.10-1.50%
- Yes Bank share price
- ₹19.911.27%
- Suzlon Energy share price
- ₹41.474.70%
- Federal Bank share price
- ₹276.000.90%
- Indian Oil Corporation share price
- ₹159.85-0.93%
Business News/Market/Market Stats/Akums Drugs and Pharmaceuticals share price/ Akums Drugs and Pharmaceuticals Profit Loss Annual
Akums Drugs and Pharmaceuticals Profit & Loss Annual
501.10 +21.50 (4.48%)Updated : 10 Mar 2026
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Operating Expense | 3,793.82 | 3,847.81 | 3,537.46 | 3,372.39 |
| Other Net | 14.40 | 13.94 | 28.32 | 6.42 |
| Diluted Weighted Average Shares | 14.96 | 15.74 | 15.74 | 15.74 |
| Gain( Loss)on Saleof Assets | 3.72 | -1.04 | 2.06 | -1.01 |
| Depreciation/ Amortization | 153.45 | 125.64 | 112.81 | 94.68 |
| Operating Income | 324.34 | 330.37 | 117.36 | 299.50 |
| Net Income | 338.18 | -4.04 | 94.85 | -252.54 |
| Income Availableto Com Excl Extra Ord | 338.18 | -4.04 | 94.85 | -252.54 |
| Other Operating Expenses Total | 55.87 | 59.22 | 63.33 | 48.29 |
| Net Income Before Taxes | 345.25 | -45.28 | 150.30 | -193.20 |
| Minority Interest | -5.60 | -4.83 | -2.96 | -1.66 |
| Net Income After Taxes | 343.78 | 0.79 | 97.82 | -250.87 |
| Income Availableto Com Incl Extra Ord | 338.18 | -4.04 | 94.85 | -252.54 |
| Costof Revenue Total | 2,629.79 | 2,743.02 | 2,454.88 | 2,488.05 |
| Gross Profit | 1,488.37 | 1,435.16 | 1,199.94 | 1,183.84 |
| Interest Inc( Exp) Net- Non- Op Total | 2.80 | -388.55 | 2.56 | -498.11 |
| Unusual Expense( Income) | -16.70 | 25.17 | 69.75 | 12.98 |
| Diluted Net Income | 338.18 | -4.04 | 94.85 | -252.54 |
| Provisionfor Income Taxes | 1.48 | -46.07 | 52.48 | 57.68 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 338.18 | -4.04 | 94.85 | -252.54 |
| Total Revenue | 4,118.16 | 4,178.18 | 3,654.82 | 3,671.89 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 4,118.16 | 4,178.18 | 3,654.82 | 3,671.89 |
| Selling/ General/ Admin Expenses Total | 971.42 | 894.75 | 836.70 | 728.40 |
| Diluted Normalized EPS | 21.25 | 0.83 | 8.83 | -15.47 |
| Diluted EPS Excluding Extra Ord Items | 22.60 | -0.26 | 6.03 | -16.04 |
| DPS- Common Stock Primary Issue | - | 0.00 | 0.00 | 0.00 |
*All figures in crores except per share values
Akums Drugs and Pharmaceuticals Quick Links
Akums Drugs and Pharmaceuticals Dividend Akums Drugs and Pharmaceuticals Bonus Akums Drugs and Pharmaceuticals News Akums Drugs and Pharmaceuticals AGM Akums Drugs and Pharmaceuticals Rights Akums Drugs and Pharmaceuticals Splits Akums Drugs and Pharmaceuticals Board Meetings Akums Drugs and Pharmaceuticals Key Metrics Akums Drugs and Pharmaceuticals Shareholdings Akums Drugs and Pharmaceuticals Balance Sheet Akums Drugs and Pharmaceuticals Cashflow Akums Drugs and Pharmaceuticals Q1 Results Akums Drugs and Pharmaceuticals Q2 Results Akums Drugs and Pharmaceuticals Q3 Results Akums Drugs and Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
382.75+7.30(1.94%)
2,359.30+14.45(0.62%)
209.15+1.10(0.53%)
1,346.55-95.20 (-6.60%)
1,339.40-86.95 (-6.10%)